Artwork
iconShare
 
Manage episode 351244397 series 2874357
Content provided by The Bioverge Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Bioverge Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Ramsey Homsany, co-founder and president of Octant Bio, sits down with Neil to discuss the company’s efforts to tackle complex diseases with next-generation small molecule drugs by harnessing synthetic biology to better understand the biochemical mechanisms of its targets, his unusual path to leadership of a biotechnology company, and Octant’s collaboration with Bristol Myers Squibb to apply its platform technologies to a set of inflammation-related pathways.
  continue reading

43 episodes